Private Equity

Dealmaking

People

Private Equity Jobs of the Week: Crosscut, GPP and Blue River are hiring

This week’s jobs include a chief of staff at Crosscut and associates at Great Point and Blue River.

2 min read · 31 August 2020

Cryoport shares rally following Blackstone's bet on cell and gene therapy; Dyal's latest GP stakes fund expected to surpass $5bn target; Levine Leichtman buys Bridgepoint Development's BigHand

Blackstone invests in Cryoport causing the latter's stock to soar and Levine Leichtman acquires BigHand from Bridgepoint Development.

2 min read · 31 August 2020

Deals

Advent’s Sovos adds a breakfast brand to its basket with fourth deal

The holding company acquired Birch Benders, which generates over $70 million in sales.

2 min read · 31 August 2020

Blackstone's bet on cell and gene therapy sends Cryoport shares skyward

For Blackstone, investing in Cryoport offers a means to ride the rapid and sustained growth of cell and gene therapy without taking on direct idiosyncratic risk.

4 min read · 28 August 2020

Deals

Why venture debt is booming

Venture lending is seen as offering higher returns for higher risk. So why, against such a volatile backdrop, is fundraising surging ahead?

6 min read · 28 August 2020

Deals

Goldman Sachs-backed Information Builders kicks off sale process

Shea & Co, a Boston-based boutique investment bank specializing in software M&A, is advising the company on its sale.

2 min read · 27 August 2020

Deals

NAMSA locks down buyer in ArchiMed

Concluding an Edgemont Partners sale process, the European suitor emerges with a deal that leaves management with an approximately 20% stake in the medical device services company.

3 min read · 27 August 2020

Consolidators brace for decision on California's controversial SB 977; Kohlberg makes big splash for Partners' PCI Pharma

Blackstone Tactical Opportunities will be investing $275 million in Cryoport to support two new acquisitions in the cell and gene therapy supply chain.

3 min read · 27 August 2020

JC Penney's sales under a magnifying glass; StoneBridge Healthcare bids for Erlanger Health System; New growth equity firm Venn Growth beefs up team

Erlanger Health System rebuffs StoneBridge's $425 million bid to acquire Erlanger Health Systems and Venn Growth expands its team while preparing to roll out a $300 million inaugural fund.

2 min read · 27 August 2020

Deals

What SB 977 could mean for PE firms investing in California's healthcare industry

If passed, SB 977 would give the California attorney general never-before-seen authority over healthcare consolidation, but not every buyer is included and there could be ways for PE firms to circumvent the law, lawyers said.

7 min read · 27 August 2020

Showing 7,881 to 7,890 of 42,641 results
1…788790…1000